Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289774639> ?p ?o ?g. }
- W4289774639 endingPage "3551" @default.
- W4289774639 startingPage "3541" @default.
- W4289774639 abstract "Patients taking adjuvant endocrine therapy (AET) after breast cancer face adherence challenges and symptom-related distress. We conducted a randomized trial to evaluate the feasibility, acceptability, and preliminary efficacy of a telehealth intervention (Symptom-Targeted Randomized Intervention for Distress and Adherence to Adjuvant Endocrine Therapy [STRIDE]) for patients taking AET.From October 2019 to June 2021, 100 patients reporting difficulty with AET were randomly assigned to either STRIDE or a medication monitoring (MedMon) control group. STRIDE included six weekly small-group videoconferencing sessions and two individual calls. We defined feasibility as having >50% of eligible patients enroll, >70% complete the 12-week assessment, and > 70% of STRIDE patients complete ≥4/6 sessions. We monitored adherence with the Medication Event Monitoring System Caps (MEMS Caps). At baseline and 12- and 24-weeks after baseline, patients self-reported adherence (Medication Adherence Report Scale), AET satisfaction (Cancer Therapy Satisfaction Questionnaire), symptom distress (Breast Cancer Prevention Trial-Symptom Checklist), self-management of symptoms (Self-efficacy for Symptom Management-AET), coping (Measure of Current Status), quality of life (QOL; Functional Assessment of Cancer Therapy-Breast), and mood (Hospital Anxiety and Depression Scale). We used linear mixed effects models to assess the effect of STRIDE on longitudinal outcomes.We enrolled 70.9% (100/141) of eligible patients; 92% completed the 12-week assessment, and 86% completed ≥4/6 STRIDE sessions. Compared with MedMon, STRIDE patients reported less symptom distress (B[difference] = -1.91; 95% CI, -3.29 to -0.52; p = .007) and better self-management of AET symptoms, coping, QOL, and mood. We did not observe significant differences in AET satisfaction or adherence.STRIDE is feasible and acceptable, showing promise for improving outcomes in patients taking AET after breast cancer.Patients taking adjuvant endocrine therapy (AET) after breast cancer may face challenges while following their treatment regimen. In this randomized controlled trial of 100 patients taking AET, a brief, small-group virtual intervention (STRIDE) was well-received by patients and led to improvements in how upset patients were due to symptoms, how confident they were in managing symptoms, and how well they could cope with stress. Thus, STRIDE is a promising intervention and should be tested in future multi-site trials." @default.
- W4289774639 created "2022-08-04" @default.
- W4289774639 creator A5007236801 @default.
- W4289774639 creator A5009871897 @default.
- W4289774639 creator A5010429902 @default.
- W4289774639 creator A5010911696 @default.
- W4289774639 creator A5032796376 @default.
- W4289774639 creator A5039694693 @default.
- W4289774639 creator A5055898059 @default.
- W4289774639 creator A5065951491 @default.
- W4289774639 creator A5073236358 @default.
- W4289774639 creator A5073757407 @default.
- W4289774639 creator A5079847756 @default.
- W4289774639 creator A5083016686 @default.
- W4289774639 creator A5088503174 @default.
- W4289774639 creator A5089144249 @default.
- W4289774639 creator A5091913728 @default.
- W4289774639 date "2022-08-04" @default.
- W4289774639 modified "2023-10-17" @default.
- W4289774639 title "A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial" @default.
- W4289774639 cites W1788956240 @default.
- W4289774639 cites W1816775564 @default.
- W4289774639 cites W1845447069 @default.
- W4289774639 cites W1857624176 @default.
- W4289774639 cites W1972110417 @default.
- W4289774639 cites W1974110731 @default.
- W4289774639 cites W1977687298 @default.
- W4289774639 cites W1979271232 @default.
- W4289774639 cites W1981266193 @default.
- W4289774639 cites W1984399073 @default.
- W4289774639 cites W1985265935 @default.
- W4289774639 cites W1987753117 @default.
- W4289774639 cites W1996337195 @default.
- W4289774639 cites W1998977165 @default.
- W4289774639 cites W2009432182 @default.
- W4289774639 cites W2013335489 @default.
- W4289774639 cites W2037940706 @default.
- W4289774639 cites W2038989281 @default.
- W4289774639 cites W2041068420 @default.
- W4289774639 cites W2044702943 @default.
- W4289774639 cites W2054309158 @default.
- W4289774639 cites W2059524444 @default.
- W4289774639 cites W2073481835 @default.
- W4289774639 cites W2108552799 @default.
- W4289774639 cites W2118728607 @default.
- W4289774639 cites W2131199058 @default.
- W4289774639 cites W2131593307 @default.
- W4289774639 cites W2133428293 @default.
- W4289774639 cites W2145166201 @default.
- W4289774639 cites W2156804290 @default.
- W4289774639 cites W2157279316 @default.
- W4289774639 cites W2166281097 @default.
- W4289774639 cites W2254514834 @default.
- W4289774639 cites W2284819073 @default.
- W4289774639 cites W2333641069 @default.
- W4289774639 cites W2473209452 @default.
- W4289774639 cites W2591189079 @default.
- W4289774639 cites W2606970653 @default.
- W4289774639 cites W2767515019 @default.
- W4289774639 cites W2786957577 @default.
- W4289774639 cites W2909503380 @default.
- W4289774639 cites W3031044133 @default.
- W4289774639 cites W3049723141 @default.
- W4289774639 cites W3099300033 @default.
- W4289774639 cites W3115995788 @default.
- W4289774639 cites W3119607706 @default.
- W4289774639 cites W3127423377 @default.
- W4289774639 cites W3153195366 @default.
- W4289774639 cites W3161059739 @default.
- W4289774639 cites W4237492363 @default.
- W4289774639 cites W4251597412 @default.
- W4289774639 cites W789208081 @default.
- W4289774639 cites W3170426587 @default.
- W4289774639 doi "https://doi.org/10.1002/cncr.34409" @default.
- W4289774639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35924869" @default.
- W4289774639 hasPublicationYear "2022" @default.
- W4289774639 type Work @default.
- W4289774639 citedByCount "8" @default.
- W4289774639 countsByYear W42897746392022 @default.
- W4289774639 countsByYear W42897746392023 @default.
- W4289774639 crossrefType "journal-article" @default.
- W4289774639 hasAuthorship W4289774639A5007236801 @default.
- W4289774639 hasAuthorship W4289774639A5009871897 @default.
- W4289774639 hasAuthorship W4289774639A5010429902 @default.
- W4289774639 hasAuthorship W4289774639A5010911696 @default.
- W4289774639 hasAuthorship W4289774639A5032796376 @default.
- W4289774639 hasAuthorship W4289774639A5039694693 @default.
- W4289774639 hasAuthorship W4289774639A5055898059 @default.
- W4289774639 hasAuthorship W4289774639A5065951491 @default.
- W4289774639 hasAuthorship W4289774639A5073236358 @default.
- W4289774639 hasAuthorship W4289774639A5073757407 @default.
- W4289774639 hasAuthorship W4289774639A5079847756 @default.
- W4289774639 hasAuthorship W4289774639A5083016686 @default.
- W4289774639 hasAuthorship W4289774639A5088503174 @default.
- W4289774639 hasAuthorship W4289774639A5089144249 @default.
- W4289774639 hasAuthorship W4289774639A5091913728 @default.
- W4289774639 hasConcept C118552586 @default.
- W4289774639 hasConcept C121608353 @default.